"Unilife Corporation (UNIS) - Product Pipeline Analysis, 2014 Update" Published

Unilife Corporation (Unilife) is a developer and commercial supplier of injectable drug delivery systems. It carries out the design, development, manufacture and distribution of safety engineered syringes for medical device and pharmaceutical industries. The company's product portfolio includes prefilled syringes, wearable injectors, auto-injectors, drug reconstitution delivery systems, ocular delivery systems and novel devices for targeted organ delivery. The company supplies its products to pharmaceutical and biotechnology companies that develop and market a range of injectable therapies to treat a multitude of acute and chronic diseases. It has 165,000 square foot manufacturing facility in York, Pennsylvania, which is registered with the US FDA for the manufacture of medical devices. The company operates in North America, Europe and Asia-Pacific. Unilife is headquartered in Pennsylvania, the US.

Full Report Details at
- http://www.fastmr.com/prod/920852_unilife_corporation_unis_product_pipeline.aspx?afid=301

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

* The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
* The report analyzes all pipeline products in development for the company Unilife Corporation
* The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
* The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
* The report provides detailed description of products in development, technical specification and functions
* The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
* Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
* To formulate effective Research & Development strategies
* Develop market-entry and market expansion strategies
* Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
* Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Boston Scientific Corporation (BSX) - Product Pipeline Analysis, 2014 Update
- Quidel Corporation (QDEL) - Product Pipeline Analysis, 2014 Update
- Unilife Corporation (UNIS) - Financial and Strategic SWOT Analysis Review
- Edwards Lifesciences Corporation (EW) - Product Pipeline Analysis, 2014 Update
- Terumo Corporation (4543) - Product Pipeline Analysis, 2014 Update